Medy-Tox (XKRX:086900) Institutional Ownership : 10.23% (As of May. 15, 2024)

View and export this data going back to 2009. Start your Free Trial

What is Medy-Tox Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Medy-Tox's institutional ownership is 10.23%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Medy-Tox's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Medy-Tox's Float Percentage Of Total Shares Outstanding is 0.00%.

Medy-Tox Institutional Ownership Historical Data

The historical data trend for Medy-Tox's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medy-Tox Institutional Ownership Chart

Medy-Tox Historical Data

The historical data trend for Medy-Tox can be seen below:

	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30
Institutional Ownership	10.46	10.68	9.65	9.93	9.79	10.64	10.30	10.22	10.26	10.23

Medy-Tox Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Medy-Tox (XKRX:086900) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medy-Tox Inc (XKRX:086900) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

641-4, Gak-Ri, Ochang-Eup, Cheongwon, KOR, 363885

Website

http://www.medytox.com

Medy-Tox Inc. is a Korea-based company engaged in the development, manufacture, and marketing of biopharmaceuticals. The company's main product is type-A botulium toxin biopharmaceuticals which are used as remedies for blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis diseases and infantile cerebral palsy. The group provides its products under the brand names of Neuronox, Siax and others. It distributes its products within Korean and to overseas markets, such as Japan, China, Russia and Europe, among others.

Medy-Tox (XKRX:086900) Headlines

No Headlines